Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
Yoshiaki Nakamura(National Cancer Center Hospital East), Takayuki Yoshino(University of Tsukuba), Hisato Kawakami(Tohoku University), Wataru Okamoto(Hiroshima University Hospital), Takako Eguchi Nakajima(St. Marianna University School of Medicine), Hiroko Ichiki(National Cancer Center Hospital East), Katsuya Tsuchihara(Chiba Cancer Center), Yoshinori Kagawa(Osaka International Cancer Institute), Justin I. Odegaard(Guardant (United States)), Masafumi Ikeda(National Cancer Center Hospital East), Atsushi Ohtsu(National Cancer Center Hospital East), Yasuyuki Kawamoto(Hokkaido University Hospital), Kentaro Yamazaki(Shizuoka Cancer Center), Yasutoshi Sakamoto(National Cancer Center Hospital East), Hideaki Bando(Aichi Cancer Center), Masayuki Hata(National Cancer Center Hospital East), Makoto Ueno(Kanagawa Prefectural Hospital Organization), Yoshiyuki Yamamoto(University of Tsukuba Hospital), Tadamichi Denda(Chiba Cancer Center), Yoshito Komatsu(Hokkaido University Hospital), Taito Esaki(National Hospital Organization Kyushu Cancer Center), Junji Furuse(Kanagawa Prefectural Hospital Organization), Naohiro Nishida(The University of Osaka), Akihito Tsuji(Kagawa University Hospital), Eiji Oki(Kyushu University), Koushiro Ohtsubo(Kanazawa University), Hisateru Yasui(Kobe City Medical Center General Hospital), Hiroya Taniguchi(National Cancer Center Hospital East), Naoki Takahashi(Saitama Cancer Center), Ken Kato(National Cancer Center Hospital East), Tomohiro Nishina(Shikoku Cancer Center), Kensei Yamaguchi(Japanese Foundation For Cancer Research), Takeshi Kato(Osaka National Hospital), Miki Izumi(National Cancer Center Hospital East), Masahiro Goto(Osaka Medical and Pharmaceutical University), Riu Yamashita(National Cancer Center Hospital East), Takeharu Yamanaka(National Cancer Center Hospital East), Nobuhisa Matsuhashi(Gifu University), Chigusa Morizane(Tokyo National Hospital)
Cited by 366
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k